dipyridamole has been researched along with Fetal Hypoxia in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Fetal Hypoxia: Deficient oxygenation of FETAL BLOOD.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fursova, ZK | 1 |
| Balika, IuD | 1 |
| Mamedalieva, NM | 1 |
| Razumovskaia, IN | 1 |
1 other study available for dipyridamole and Fetal Hypoxia
| Article | Year |
|---|---|
[Characteristics of lymphocytic enzyme status of the newborn after metabolic therapy of pregnant women].
Topics: Abortion, Habitual; Benzenesulfonates; Dipyridamole; Estradiol Congeners; Female; Fetal Growth Retar | 1995 |